Lisata Therapeutics, Inc.
LSTA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000320017
No open-market purchases or sales by Lisata Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $3.70M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Lisata Therapeutics, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 21 | 22 | +1 |
| Shares | 785.7K | 783.4K | −2.37K (−0.3%) |
| Value | $2.33M | $1.84M | −$492.9K (−21.1%) |
New holders (3)
Institutions that held Lisata Therapeutics, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Northern Trust Corp | 10,268 | $24.1K | 0.00% |
| Cheviot Value Management, LLC | 3 | $7 | 0.00% |
| Loring Wolcott & Coolidge Fiduciary Advisors LLP | 2 | $5 | 0.00% |
Sold out (2)
Institutions that held Lisata Therapeutics, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Citadel Advisors LLC | 23,273 | $69.4K |
| Advisor Group Holdings, Inc. | 1 | $2 |